Genomic reconstruction of the SARS-CoV-2 epidemic in England.

Harald SVöhringer; TheoSanderson; Matthew Sinnott ORCID logo; NicolaDe Maio; ThuyNguyen; Richard Goater ORCID logo; FrankSchwach; Ian Harrison ORCID logo; Joel Hellewell ORCID logo; Cristina VAriani; +19 more... SoniaGonçalves; David K Jackson ORCID logo; IanJohnston; Alexander WJung; Callum Saint ORCID logo; JohnSillitoe; MariaSuciu; Nick Goldman ORCID logo; Jasmina Panovska-Griffiths ORCID logo; Wellcome Sanger Institute COVID-19 Surveillance Team; COVID-19 Genomics UK (COG-UK) Consortium*; Ewan Birney ORCID logo; Erik Volz ORCID logo; Sebastian Funk ORCID logo; Dominic Kwiatkowski ORCID logo; MeeraChand; Inigo Martincorena ORCID logo; Jeffrey C Barrett ORCID logo; Moritz Gerstung ORCID logo; (2021) Genomic reconstruction of the SARS-CoV-2 epidemic in England. NATURE, 600 (7889). pp. 506-511. ISSN 0028-0836 DOI: 10.1038/s41586-021-04069-y
Copy

The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological characterization. Here we use the dense genomic surveillance data generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 71 different lineages in each of 315 English local authorities between September 2020 and June 2021. This analysis reveals a series of subepidemics that peaked in early autumn 2020, followed by a jump in transmissibility of the B.1.1.7/Alpha lineage. The Alpha variant grew when other lineages declined during the second national lockdown and regionally tiered restrictions between November and December 2020. A third more stringent national lockdown suppressed the Alpha variant and eliminated nearly all other lineages in early 2021. Yet a series of variants (most of which contained the spike E484K mutation) defied these trends and persisted at moderately increasing proportions. However, by accounting for sustained introductions, we found that the transmissibility of these variants is unlikely to have exceeded the transmissibility of the Alpha variant. Finally, B.1.617.2/Delta was repeatedly introduced in England and grew rapidly in early summer 2021, constituting approximately 98% of sampled SARS-CoV-2 genomes on 26 June 2021.



picture_as_pdf
Genomic reconstruction of the SARS-CoV-2 epidemic in England.pdf
subject
Published Version
Available under Creative Commons: 4.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work associated with the research centre(s):

Find work from this publication: